Situation of oncological patients during COVID-19 pandemic with particular emphasis on lung cancer patients
DOI:
https://doi.org/10.12775/JEHS.2021.11.09.066Keywords
COVID-19, Telemedicine, Lung cancer, pandemicAbstract
Introduction and purpose: The purpose of this study is to review literature about alterations to treatment regimens to lung cancer during COVID-19 pandemic accessible on PubMed platform. In pulmonary neoplasms, early diagnosis and treatment is a key to ensure patient safety. Burdening of healthcare systems during pandemic has resulted in many obstacles in oncologic treatment.
A brief description of the state of knowledge: The lung cancer is the most frequent and the most deadly cancer in men and women. COVID-19 is a pulmonary infectious disease whose spread around the world has resulted in a pandemic. At the onset of the worldwide pandemic, many institutions, including healthcare facilities were closed, making it more difficult to provide oncological patients the treatment compliant with the standards. The anxiety of patients caused by the pandemic has caused delays in treatment that can cause progression of the disease. In patients with lung cancer mortality of COVID-19 was around 50%, which made their visits at hospital hazardous. Before the accessibility of anti-COVID-19 vaccines telemedical healthcare was one of the ways to provide healthcare to oncological patients.
Conclusions: Patients with lung cancer are one of the risk groups of COVID-19. Delays in their treatment caused by the pandemic are potentially dangerous and negatively affect the therapy. Telemedicine is a useful too provide medical care, but has its own limitations.
References
Czeisler MÉ, Marynak K, Clarke KEN, Salah Z, Shakya I, Thierry JM, Ali N, McMillan H, Wiley JF, Weaver MD, Czeisler CA, Rajaratnam SMW, Howard ME. Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns - United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257. doi: 10.15585/mmwr.mm6936a4. PMID: 32915166; PMCID: PMC7499838.
Hamilton W. Cancer diagnostic delay in the COVID-19 era: what happens next? Lancet Oncol. 2020 Aug;21(8):1000-1002. doi: 10.1016/S1470-2045(20)30391-0. Epub 2020 Jul 20. PMID: 32702312; PMCID: PMC7834491.
Gheorghe A, Maringe C, Spice J, Purushotham A, Chalkidou K, Rachet B, Sullivan R, Aggarwal A. Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK. Eur J Cancer. 2021 Jul;152:233-242. doi: 10.1016/j.ejca.2021.04.019. Epub 2021 May 5. PMID: 34049776.
Dingemans AC, Soo RA, Jazieh AR, Rice SJ, Kim YT, Teo LLS, Warren GW, Xiao SY, Smit EF, Aerts JG, Yoon SH, Veronesi G, De Cobelli F, Ramalingam SS, Garassino MC, Wynes MW, Behera M, Haanen J, Lu S, Peters S, Ahn MJ, Scagliotti GV, Adjei AA, Belani CP. Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic. J Thorac Oncol. 2020 Jul;15(7):1119-1136. doi: 10.1016/j.jtho.2020.05.001. Epub 2020 May 15. PMID: 32422364; PMCID: PMC7227539.
Sud A, Torr B, Jones ME, Broggio J, Scott S, Loveday C, Garrett A, Gronthoud F, Nicol DL, Jhanji S, Boyce SA, Williams M, Riboli E, Muller DC, Kipps E, Larkin J, Navani N, Swanton C, Lyratzopoulos G, McFerran E, Lawler M, Houlston R, Turnbull C. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020 Aug;21(8):1035-1044. doi: 10.1016/S1470-2045(20)30392-2. Epub 2020 Jul 20. PMID: 32702311; PMCID: PMC7116538.
Barta JA, Powell CA, Wisnivesky JP. Global Epidemiology of Lung Cancer. Ann Glob Health. 2019 Jan 22;85(1):8. doi: 10.5334/aogh.2419. PMID: 30741509; PMCID: PMC6724220.
Zadnik V, Mihor A, Tomsic S, Zagar T, Bric N, Lokar K, Oblak I. Impact of COVID-19 on cancer diagnosis and management in Slovenia - preliminary results. Radiol Oncol. 2020 Jul 29;54(3):329-334. doi: 10.2478/raon-2020-0048. PMID: 32726291; PMCID: PMC7409606.
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance, [accessed 20.12.2020].
https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic, [accessed 21.12.2020].
https://www.nhs.uk/conditions/coronavirus-covid-19/self-isolation-and-treatment/, [accessed 21.12.2020].
Brooke J, Jackson D. Older people and COVID-19: Isolation, risk and ageism. J Clin Nurs. 2020 Jul;29(13-14):2044-2046. doi: 10.1111/jocn.15274. Epub 2020 May 5. PMID: 32239784.
Pytka M, Zywicka A, Makaruk M, Szalach M, Dalmata W. Telemedycyna w dobie pandemii COVID-19 oczami lekarza i pacjenta. Tygiel, Komunikacja wyzwaniem współczesnej medycyny, 2020 Sep;23
Saltzman LY, Hansel TC, Bordnick PS. Loneliness, isolation, and social support factors in post-COVID-19 mental health. Psychol Trauma. 2020 Aug;12(S1):S55-S57. doi: 10.1037/tra0000703. Epub 2020 Jun 18. PMID: 32551762.
Herbert TB, Cohen S. Stress and immunity in humans: a meta-analytic review. Psychosom Med. 1993 Jul-Aug;55(4):364-79. doi: 10.1097/00006842-199307000-00004. PMID: 8416086.
Novel Coronavirus (2019-nCoV) Situation Report, World Health Organization (WHO)
Calles A, Aparicio MI, Alva M, Bringas M, Gutierrez N, Soto J, Arregui M, Tirado VC, Álvarez EL, Del Monte-Millán M, Massarrah T, Galera M, Álvarez R, Martín M. Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid. Front Oncol. 2020 Sep 16;10:1777. doi: 10.3389/fonc.2020.01777. PMID: 33042826; PMCID: PMC7525070.
Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017 Jul;39(5):529-539. doi: 10.1007/s00281-017-0629-x. Epub 2017 May 2. PMID: 28466096; PMCID: PMC7079893.
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14. PMID: 32066541; PMCID: PMC7159000.
Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, Zhang Z, You H, Wu M, Zheng Q, Xiong Y, Xiong H, Wang C, Chen C, Xiong F, Zhang Y, Peng Y, Ge S, Zhen B, Yu T, Wang L, Wang H, Liu Y, Chen Y, Mei J, Gao X, Li Z, Gan L, He C, Li Z, Shi Y, Qi Y, Yang J, Tenen DG, Chai L, Mucci LA, Santillana M, Cai H. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discov. 2020 Jun;10(6):783-791. doi: 10.1158/2159-8290.CD-20-0422. Epub 2020 Apr 28. PMID: 32345594; PMCID: PMC7309152.
Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, Bogler Y, Caldararo M, Figueroa CJ, Glickman MS, Joanow A, Kaltsas A, Lee YJ, Lucca A, Mariano A, Morjaria S, Nawar T, Papanicolaou GA, Predmore J, Redelman-Sidi G, Schmidt E, Seo SK, Sepkowitz K, Shah MK, Wolchok JD, Hohl TM, Taur Y, Kamboj M. Determinants of COVID-19 disease severity in patients with cancer. Nat Med. 2020 Aug;26(8):1218-1223. doi: 10.1038/s41591-020-0979-0. Epub 2020 Jun 24. PMID: 32581323; PMCID: PMC7785283.
Garassino MC, Whisenant JG, Huang LC, Trama A, Torri V, Agustoni F, Baena J, Banna G, Berardi R, Bettini AC, Bria E, Brighenti M, Cadranel J, De Toma A, Chini C, Cortellini A, Felip E, Finocchiaro G, Garrido P, Genova C, Giusti R, Gregorc V, Grossi F, Grosso F, Intagliata S, La Verde N, Liu SV, Mazieres J, Mercadante E, Michielin O, Minuti G, Moro-Sibilot D, Pasello G, Passaro A, Scotti V, Solli P, Stroppa E, Tiseo M, Viscardi G, Voltolini L, Wu YL, Zai S, Pancaldi V, Dingemans AM, Van Meerbeeck J, Barlesi F, Wakelee H, Peters S, Horn L; TERAVOLT investigators. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020 Jul;21(7):914-922. doi: 10.1016/S1470-2045(20)30314-4. Epub 2020 Jun 12. PMID: 32539942; PMCID: PMC7292610.
He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, Wu D, Liang B, Lu X, Ma Y, Li L, Wang H, Chen Z, Li Q, Gale RP. COVID-19 in persons with haematological cancers. Leukemia. 2020 Jun;34(6):1637-1645. doi: 10.1038/s41375-020-0836-7. Epub 2020 Apr 24. PMID: 32332856; PMCID: PMC7180672.
Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020 Apr;21(4):e180. doi: 10.1016/S1470-2045(20)30150-9. Epub 2020 Mar 3. PMID: 32142622; PMCID: PMC7130057.
Rashedi J, Mahdavi Poor B, Asgharzadeh V, Pourostadi M, Samadi Kafil H, Vegari A, Tayebi-Khosroshahi H, Asgharzadeh M. Risk Factors for COVID-19. Infez Med. 2020 Dec 1;28(4):469-474. PMID: 33257620.
Mgbako O, Miller EH, Santoro AF, Remien RH, Shalev N, Olender S,Gordon P, Sobieszczyk ME. COVID-19, Telemedicine, and PatientEmpowerment in HIV Care and Research. AIDS Behav. 2020 Jul;24(7):1990-1993. doi: 10.1007/s10461-020-02926-x. PMID:32440970; PMCID: PMC7241062.
Elkaddoum R, Haddad FG, Eid R, Kourie HR. Telemedicine for cancer patients during COVID-19 pandemic: between threats and opportunities. Future Oncol. 2020 Jun;16(18):1225-1227. doi: 10.2217/fon-2020-0324. Epub 2020 May 1. PMID: 32356460; PMCID: PMC7202358.
Boehm K, Ziewers S, Brandt MP, Sparwasser P, Haack M, Willems F, Thomas A, Dotzauer R, Höfner T, Tsaur I, Haferkamp A, Borgmann H. Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients' Perspective. Eur Urol. 2020 Jul;78(1):16-20. doi: 10.1016/j.eururo.2020.04.055. Epub 2020 Apr 27. PMID: 32362498; PMCID: PMC7183955.
Tsamakis K, Gavriatopoulou M, Schizas D, Stravodimou A, Mougkou A, Tsiptsios D, Sioulas V, Spartalis E, Sioulas AD, Tsamakis C, Charalampakis N, Mueller C, Arya D, Zarogoulidis P, Spandidos DA, Dimopoulos MA, Papageorgiou C, Rizos E. Oncology during the COVID-19 pandemic: challenges, dilemmas and the psychosocial impact on cancer patients. Oncol Lett. 2020 Jul;20(1):441-447. doi: 10.3892/ol.2020.11599. Epub 2020 May 8. PMID: 32565968; PMCID: PMC7285823.
Ashry AH, Alsawy MF. Doctor-patient distancing: an early experience of telemedicine for postoperative neurosurgical care in the time of COVID-19. Egypt J Neurol Psychiatr Neurosurg. 2020;56(1):80. doi: 10.1186/s41983-020-00212-0. Epub 2020 Jul 23. PMID: 32834718; PMCID: PMC7376313.
Uscher-Pines L, Sousa J, Raja P, Mehrotra A, Barnett ML, Huskamp HA. Suddenly Becoming a "Virtual Doctor": Experiences of Psychiatrists Transitioning to Telemedicine During the COVID-19 Pandemic. Psychiatr Serv. 2020 Nov 1;71(11):1143-1150. doi: 10.1176/appi.ps.202000250. Epub 2020 Sep 16. PMID: 32933411; PMCID: PMC7606640.
National Institute for Health and Care Excellence (NICE) “COVID-19 rapid guideline: managing COVID-19” dostęp z dnia: 23.09.2021 r.
Calles A, Aparicio MI, Alva M, Bringas M, Gutierrez N, Soto J, Arregui M, Tirado VC, Álvarez EL, Del Monte-Millán M, Massarrah T, Galera M, Álvarez R, Martín M. Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid. Front Oncol. 2020 Sep 16;10:1777. doi: 10.3389/fonc.2020.01777. PMID: 33042826; PMCID: PMC7525070.
Bade BC, Dela Cruz CS. Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med. 2020 Mar;41(1):1-24. doi: 10.1016/j.ccm.2019.10.001. PMID: 32008623.
Feletto E, Grogan P, Nickson C, Smith M, Canfell K. How has COVID-19 impacted cancer screening? Adaptation of services and the future outlook in Australia. Public Health Res Pract. 2020 Dec 9;30(4):3042026. doi: 10.17061/phrp3042026. PMID: 33294902.
Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, Rachet B, Aggarwal A. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020 Aug;21(8):1023-1034. doi: 10.1016/S1470-2045(20)30388-0. Epub 2020 Jul 20. Erratum in: Lancet Oncol. 2021 Jan;22(1):e5. PMID: 32702310; PMCID: PMC7417808.
Singh AP, Berman AT, Marmarelis ME, Haas AR, Feigenberg SJ, Braun J, Ciunci CA, Bauml JM, Cohen RB, Kucharczuk JC, Shulman LN, Langer CJ, Aggarwal C. Management of Lung Cancer During the COVID-19 Pandemic. JCO Oncol Pract. 2020 Sep;16(9):579-586. doi: 10.1200/OP.20.00286. Epub 2020 May 26. PMID: 32453656.
Ribas A, Sengupta R, Locke T, Zaidi SK, Campbell KM, Carethers JM, Jaffee EM, Wherry EJ, Soria JC, D'Souza G; AACR COVID-19 and Cancer Task Force. Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited. Cancer Discov. 2021 Feb;11(2):233-236. doi: 10.1158/2159-8290.CD-20-1817. Epub 2020 Dec 19. PMID: 33355178; PMCID: PMC8053003.
Fujita K, Ito T, Saito Z, Kanai O, Nakatani K, Mio T. Impact of COVID-19 pandemic on lung cancer treatment scheduling. Thorac Cancer. 2020 Oct;11(10):2983-2986. doi: 10.1111/1759-7714.13615. Epub 2020 Aug 12. PMID: 32790028; PMCID: PMC7436133.
Sha Z, Chang K, Mi J, Liang Z, Hu L, Long F, Shi H, Lin Z, Wang X, Pei X. The impact of the COVID-19 pandemic on lung cancer patients. Ann Palliat Med. 2020 Sep;9(5):3373-3378. doi: 10.21037/apm-20-1662. PMID: 33065788.
Zadnik V, Mihor A, Tomsic S, Zagar T, Bric N, Lokar K, Oblak I. Impact of COVID-19 on cancer diagnosis and management in Slovenia - preliminary results. Radiol Oncol. 2020 Jul 29;54(3):329-334. doi: 10.2478/raon-2020-0048. PMID: 32726291; PMCID: PMC7409606.
Rogado J, Pangua C, Serrano-Montero G, Obispo B, Marino AM, Pérez-Pérez M, López-Alfonso A, Gullón P, Lara MÁ. Covid-19 and lung cancer: A greater fatality rate? Lung Cancer. 2020 Aug;146:19-22. doi: 10.1016/j.lungcan.2020.05.034. Epub 2020 May 30. PMID: 32505076; PMCID: PMC7260554.
Jee J, Foote MB, Lumish M, Stonestrom AJ, Wills B, Narendra V, Avutu V, Murciano-Goroff YR, Chan JE, Derkach A, Philip J, Belenkaya R, Kerpelev M, Maloy M, Watson A, Fong C, Janjigian Y, Diaz LA Jr, Bolton KL, Pessin MS. Chemotherapy and COVID-19 Outcomes in Patients With Cancer. J Clin Oncol. 2020 Oct 20;38(30):3538-3546. doi: 10.1200/JCO.20.01307. Epub 2020 Aug 14. PMID: 32795225; PMCID: PMC7571792.
Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, Pradhan K, Thota R, Reissman S, Sparano JA, Gartrell BA, Smith RV, Ohri N, Garg M, Racine AD, Kalnicki S, Perez-Soler R, Halmos B, Verma A. Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System. Cancer Discov. 2020 Jul;10(7):935-941. doi: 10.1158/2159-8290.CD-20-0516. Epub 2020 May 1. PMID: 32357994; PMCID: PMC7334098.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 © The Author(s)
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 382
Number of citations: 0